Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR

20.51  -0.11 (-0.53%)

Fundamental Rating

3

ICAD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
ICAD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
Each year in the past 5 years ICAD had a positive operating cash flow.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -2.62%, ICAD is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -6.38%, ICAD is doing worse than 83.33% of the companies in the same industry.
With a Return On Invested Capital value of 1.77%, ICAD is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.57%.
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROIC 1.77%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 13.47%, ICAD is doing worse than 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of ICAD has declined.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 13.47%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
The number of shares outstanding for ICAD has been increased compared to 5 years ago.
ICAD has a worse debt/assets ratio than last year.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.82. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
ICAD's Altman-Z score of 0.82 is on the low side compared to the rest of the industry. ICAD is outperformed by 61.90% of its industry peers.
The Debt to FCF ratio of ICAD is 28.49, which is on the high side as it means it would take ICAD, 28.49 years of fcf income to pay off all of its debts.
ICAD's Debt to FCF ratio of 28.49 is on the low side compared to the rest of the industry. ICAD is outperformed by 71.43% of its industry peers.
A Debt/Equity ratio of 0.99 indicates that ICAD is somewhat dependend on debt financing.
ICAD's Debt to Equity ratio of 0.99 is on the low side compared to the rest of the industry. ICAD is outperformed by 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Altman-Z 0.82
ROIC/WACC0.64
WACC2.77%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.84 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD has a Current ratio of 1.84. This is amongst the best in the industry. ICAD outperforms 88.10% of its industry peers.
ICAD has a Quick Ratio of 1.55. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, ICAD belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.55
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2

3. Growth

3.1 Past

ICAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.06%, which is quite good.
The Earnings Per Share has been decreasing by -9.69% on average over the past years.
The Revenue has decreased by -5.13% in the past year.
Measured over the past years, ICAD shows a small growth in Revenue. The Revenue has been growing by 0.64% on average per year.
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%

3.2 Future

ICAD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.73% yearly.
ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.82% yearly.
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.49 indicates a rather cheap valuation of ICAD.
ICAD's Price/Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 97.62% of the companies in the same industry.
ICAD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 6.06 indicates a rather cheap valuation of ICAD.
95.24% of the companies in the same industry are more expensive than ICAD, based on the Price/Forward Earnings ratio.
ICAD is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.49
Fwd PE 6.06
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICAD is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ICAD is valued a bit cheaper than the industry average as 73.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.41
EV/EBITDA 14.63
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.61%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 5.56.
Compared to an average S&P500 Dividend Yield of 2.35, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.61%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-132.91%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (7/14/2025, 5:29:22 PM)

20.51

-0.11 (-0.53%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)07-23 2025-07-23
Inst Owners72.7%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts71
Price Target25.92 (26.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.61%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-132.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.57%
PT rev (3m)-7.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.66%
Valuation
Industry RankSector Rank
PE 6.49
Fwd PE 6.06
P/S 0.99
P/FCF 9.41
P/OCF 4.27
P/B 0.36
P/tB 0.36
EV/EBITDA 14.63
EPS(TTM)3.16
EY15.41%
EPS(NY)3.39
Fwd EY16.51%
FCF(TTM)2.18
FCFY10.63%
OCF(TTM)4.81
OCFY23.43%
SpS20.62
BVpS56.72
TBVpS56.26
PEG (NY)0.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROCE 2.53%
ROIC 1.77%
ROICexc 1.97%
ROICexgc 1.98%
OM 13.47%
PM (TTM) N/A
GM N/A
FCFM 10.57%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Debt/EBITDA 13.44
Cap/Depr 187.28%
Cap/Sales 12.74%
Interest Coverage 2.79
Cash Conversion 115%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.55
Altman-Z 0.82
F-Score7
WACC2.77%
ROIC/WACC0.64
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
EBIT growth 1Y-17.53%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.67%
FCF growth 1Y4516.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%